Wednesday, September 23, 2026

TagsCellenkos

Tag: Cellenkos

Healthcare

Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)

BFN's Desk - May 5, 2026 0

Healthcare

Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia

BFN's Desk - April 27, 2026 0

Most Read

House of McDowell’s Soda Reimagines Yaari with ‘Yaari Ki Nayi Vibe’

September 20, 2026

Black Dog Scotch Whisky In New Packaging

September 11, 2026

Madhya Pradesh Unveils Roadmap to Cut Major Non-CO₂ Pollutants

September 8, 2026

Sanchi Gets a New Identity in Indore, Reinforcing Its 45-Year Legacy of Trust

August 26, 2026